Gufic Biosciences Statistics

Total Valuation

NSE:GUFICBIO has a market cap or net worth of INR 37.29 billion. The enterprise value is 40.36 billion.

Market Cap	37.29B
Enterprise Value	40.36B

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	Sep 17, 2024

Share Statistics

Current Share Class	100.28M
Shares Outstanding	n/a
Shares Change (YoY)	+1.72%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	24.82M

Valuation Ratios

The trailing PE ratio is 53.54.

PE Ratio	53.54
Forward PE	n/a
PS Ratio	4.55
PB Ratio	6.20
P/TBV Ratio	6.27
P/FCF Ratio	79.28
P/OCF Ratio	30.43
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.97, with an EV/FCF ratio of 85.81.

EV / Earnings	57.95
EV / Sales	4.92
EV / EBITDA	29.97
EV / EBIT	35.52
EV / FCF	85.81

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.56.

Current Ratio	1.61
Quick Ratio	0.89
Debt / Equity	0.56
Debt / EBITDA	2.50
Debt / FCF	7.15
Interest Coverage	4.92

Financial Efficiency

Return on equity (ROE) is 12.29% and return on invested capital (ROIC) is 7.88%.

Return on Equity (ROE)	12.29%
Return on Assets (ROA)	6.28%
Return on Invested Capital (ROIC)	7.88%
Return on Capital Employed (ROCE)	14.53%
Revenue Per Employee	5.50M
Profits Per Employee	467,133
Employee Count	1,491
Asset Turnover	0.72
Inventory Turnover	1.80

Taxes

In the past 12 months, NSE:GUFICBIO has paid 244.95 million in taxes.

Income Tax	244.95M
Effective Tax Rate	26.02%

Stock Price Statistics

Beta (5Y)	0.33
52-Week Price Change	n/a
50-Day Moving Average	362.80
200-Day Moving Average	400.24
Relative Strength Index (RSI)	48.96
Average Volume (20 Days)	52,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:GUFICBIO had revenue of INR 8.20 billion and earned 696.50 million in profits. Earnings per share was 6.95.

Revenue	8.20B
Gross Profit	4.45B
Operating Income	1.14B
Pretax Income	941.43M
Net Income	696.50M
EBITDA	1.35B
EBIT	1.14B
Earnings Per Share (EPS)	6.95

Full Income Statement

Balance Sheet

The company has 290.22 million in cash and 3.36 billion in debt, giving a net cash position of -3.07 billion.

Cash & Cash Equivalents	290.22M
Total Debt	3.36B
Net Cash	-3.07B
Net Cash Per Share	n/a
Equity (Book Value)	6.01B
Book Value Per Share	59.96
Working Capital	2.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.23 billion and capital expenditures -755.26 million, giving a free cash flow of 470.43 million.

Operating Cash Flow	1.23B
Capital Expenditures	-755.26M
Free Cash Flow	470.43M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 54.29%, with operating and profit margins of 13.86% and 8.50%.

Gross Margin	54.29%
Operating Margin	13.86%
Pretax Margin	11.48%
Profit Margin	8.50%
EBITDA Margin	16.43%
EBIT Margin	13.86%
FCF Margin	5.74%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.

Dividend Per Share	0.10
Dividend Yield	0.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	1.44%
Buyback Yield	-1.72%
Shareholder Yield	-1.69%
Earnings Yield	1.87%
FCF Yield	1.26%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6